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Abstract
Background: Regarding demographic changes in Germany it can be assumed that the number of
elderly and the resulting need for long term care is increasing in the near future. It is not only an
individual's interest but also of public concern to avoid a nursing home admission. Current evidence
indicates that preventive home visits can be an effective way to reduce the admission rate in this
way making it possible for elderly people to stay longer at home than without home visits. As the
effectiveness and cost-effectiveness of preventive home visits strongly depends on existing services
in the social and health system existing international results cannot be merely transferred to
Germany. Therefore it is necessary to investigate the effectiveness and cost-effectiveness of such
an intervention in Germany by a randomized controlled trial.
Methods: The trial is designed as a prospective multi-center randomized controlled trial in the
cities of Halle and Leipzig. The trial includes an intervention and a control group. The control group
receives usual care. The intervention group receives three additional home visits by non-physician
health professionals (1) geriatric assessment, (2) consultation, (3) booster session.
The nursing home admission rate after 18 months will be defined as the primary outcome. An
absolute risk reduction from a 20% in the control-group to a 7% admission rate in the intervention
group including an assumed drop out rate of 30% resulted in a required sample size of N = 320 (n
= 160 vs. n = 160).
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Parallel to the clinical outcome measurement the intervention will be evaluated economically. The
economic evaluation will be performed from a society perspective.
Discussion: To the authors' knowledge for the first time a trial will investigate the effectiveness
and cost-effectiveness of preventive home visits for people aged 80 and over in Germany using the
design of a randomized controlled trial. Thus, the trial will contribute to the existing evidence on
preventive home visits especially in Germany.
Background
It can be stated as an obvious fact that people prefer to age
at home in a familiar environment then to move to a nurs-
ing institution. Considering the aim of an autonomous
and independent life as a central aspect of successful liv-
ing in the older population, measures to achieve this aim
have to be taken.
In modern industrialized countries traditional forms of
support for the elderly are often replaced by new formal
and informal support systems. This shift happened as a
consequence of demographic and social changes in the
19th and 20th century. Concerns about the well-being of
the elderly population grew especially in the second half
of the 20th century as problems arose to afford for the care
of the growing number of elderly people. In addition to
the mentioned structural changes a reduced commitment
to care for elderly family members is forecasted in indus-
trialized countries.
Data from the German Federal Statistical Office indicates
a total prevalence of people aged 80 and over that are
cared for in nursing homes of 13% in the relevant German
population [1]. A survey in Leipzig showed that about
27.8% of the population in nursing homes is between 80
and 84 years and even 60.8% is 85 years and older [2].
Relevant reductions of self care skills were found in 61.8%
of the people 80 years or older [2]. To give concise prog-
nosis of necessary nursing care 3 main factors have to be
taken into account:
(1) Demographic developments (declining familial
potential for nursing),
(2) Structural changes in society (increased female
employment; increasing number of single-person house-
holds) and
(3) Cultural changes (decreasing commitment to nurse
relatives).
Some authors extrapolate a 60% increase in the preva-
lence of people in need of long term care assuming a mod-
erate increase in average life expectancy within the next 30
years [3], and assuming a higher increase in average life
expectancy the increase would be even higher [3,4]. Con-
sequently the need for inpatient care will rise accordingly.
Inpatient care like residential care homes or nursing
homes causes higher social costs than ambulatory care. An
absolute or relative increase in admission rates thus
would put a higher strain on the long term care insurance
system in Germany [5,6]. Efficient measures to reduce the
prevalence of nursing home admissions by either avoid-
ing or delaying admission have to be investigated.
Preliminary models of preventive home visit interven-
tions were developed in Denmark and the United King-
dom [7]. More then twenty years after the first
intervention programs the concept of preventive home
visits has been developed to multidimensional assess-
ments accompanied by multidimensional interventions.
As care for the elderly includes several dimensions these
dimensions are represented in contemporary home visit
programs. They include the socioeconomic supportive
dimension, the social integrative dimension and finally
the health dimension. The individual assessment of these
dimensions is meant to identify individual risk factors or
a decline of functioning, leading to a need for individual
intervention strategies. The concept of home visits has the
advantage to assess functioning in an individual's relevant
environment [8,9]. In the most recent meta-analysis [10]
26 trials investigating preventive home visits were identi-
fied. The included trials were conducted in 8 different
countries but Germany was not included. Results regard-
ing the effectiveness of preventive home visits are dis-
cussed very controversially within the reviews and a strong
clinical heterogeneity can be stated across the existing
publications [9,10]. As such complex interventions may
be highly sensitive to the local health system the general-
izability of international results to Germany is limited.
For that reason it is important to develop and investigate
a concept of preventive home visits in Germany that
accommodates local structures.
The aim of our study therefore is to investigate the effects
of preventive home visits in Germany in people aged 80
and older. Our hypothesis is: Preventive home visits will
reduce the incidence of nursing home admissions within
the investigated period of 18 months. Furthermore we
expect the intervention to be cost-effective. The results can
be used as a basis for recommendations on the fundingBMC Public Health 2008, 8:185 http://www.biomedcentral.com/1471-2458/8/185
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and implementation of preventive home visits in Ger-
many.
Methods
This multi center trial is based on a non-blinded rand-
omized controlled study design. We have 2 centers
included in this trial, Halle (Saxony-Anhalt) and Leipzig
(Saxony). The control group receives usual care besides
the baseline and the final measurement after 18 months
while the intervention group additionally receives a geri-
atric assessment, a consultation visit and a booster ses-
sion.
Inclusion and exclusion criteria
The study is conducted in cooperation with the university
hospital Halle, the Diakoniekrankenhaus Halle, the regis-
tration office Halle and 3 GP practices in the city of Halle
and 18 GP practices in the city of Leipzig. All people older
than 80, fluent German speakers, residents of Leipzig or
Halle, living at home or planned discharge to home (hos-
pital patients) are eligible for this study. Additionally, par-
ticipants have to be impaired in at least 3 activities of daily
living. We exclude from trial participation people that are
cognitive impaired, not able to give informed consent or
have a care level higher than I (according to German long
term care insurance).
Recruitment of participants
It is a well documented problem to recruit participants in
this age group especially when interventions that demand
home visitation are involved [11]. We therefore will
implement three strategies to maximize recruitment and
reach the needed sample size. The primary recruitment
strategy is via GP practices in the cities of Halle and Leip-
zig. As a second strategy the recruitment via liaison nurses
will be implemented in hospitals in Halle to cope with the
small number of participating GPs and to include a group
of high risk participants. As a third recruitment strategy
people aged 80 and over in Halle and Leipzig will be con-
tacted by mail. Addresses will be retrieved by cooperating
with the local registration offices. We will send explicit
trial information, a consent form for participants and a
self-addressed stamped envelope. After return of the con-
sent form we will contact the responders by telephone,
prescreen for inclusion and exclusion criteria and make an
appointment for a home visit. This first home visit is dif-
ferent to the first home visits of the other recruitment
methods so far that the screening is done within that visit
in addition to the assessment. Prescreening and final
screening is necessary as we expect a certain amount of
inappropriate responders to our letter. We will set a time
limit of 4 weeks after dispatch of the last letter till we close
participant registration via mail. All received consent let-
ters then will be put in random order. This will be the
order we contact the persons until we got enough study
participants in addition to general practitioners' practices
and hospital recruitment. Exceeding persons will get a
written cancellation due to numerical limitation for trial
participants.
Randomization
A balanced block-wise randomization, stratified by center,
will be used. In Halle the sample additionally is stratified
according to the recruiting hospital and practice. Conceal-
ment of allocation is assured by central randomization via
consecutive randomization lists in the order of recruit-
ment.
Participants recruited via the registration office will be
randomized using sealed opaque envelopes immediately
after completion of the baseline assessment.
Blinding
Patients and field researchers cannot be blinded to group
allocation. A blinded statistician not involved in trial con-
duct will do the final analysis.
Study procedure
A liaison nurses screens and recruits the participants for
eligibility in the 2 hospitals in Halle. Medical secretaries
screen and recruit the participants in Leipzig and Halle for
eligibility in the participating GPs' practices. Patients then
are randomized by the local study center via consecutive
randomization lists in this way assuring concealed alloca-
tion of participants. The participants are contacted by the
centers' study personal via mail and phone. In the phone
call an appointment for the first home visit is made with
the patients. In Halle we additionally will contact the
patients after discharge from hospital. All other study pro-
cedures are standardized across the study centers, in this
way ensuring a homogenous conduct of the trial.
The intervention group will be assessed with a geriatric
assessment and the baseline assessment. A team of nurses,
psychologists, physiotherapists, dietitians and physicians
will work out individualized recommendations in a case
review one week after the geriatric assessment. The main
aim is to identify self-care deficits and risks for self-care
deficits in the socioeconomic supportive dimension, the
social integrative dimension and finally the health dimen-
sion. Then appropriate recommendations will be given by
the team. After the case conference the members of the
intervention group are visited by the same staff member
again. This staff member will conduct a consultation and
instruction based on the results of the case conference.
Four weeks after the consultation another visit is done by
the staff member. This visit (booster session) is for evalu-
ative purposes mainly: To what extent the study partici-
pant adheres to the recommendations and how
convenient are the recommendations. The final measure-BMC Public Health 2008, 8:185 http://www.biomedcentral.com/1471-2458/8/185
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ment will be the follow-up assessment 18 months after
baseline.
The control group is only assessed with the baseline
assessment and the follow-up assessment 18 months
later. The control group will not receive any intervention
in addition to standard care. The flow of the participants
is shown in Figure 1.
Outcomes
Primary outcome of our trial is the incidence of nursing
home admission over the study period of 18 months.
Nursing home admission in our trial is defined as the per-
manent admission into an inpatient nursing care facility
according to the social security code of Germany. Short
term care, assisted living, geriatric day care or respite care
facilities are not included in this definition.
Data will be collected on follow-up assessment either by
direct contact with the participants, their relatives or the
resident registration office.
Secondary outcomes over the whole trial period of 18
months:
￿ Time to nursing home admission
￿ health care service utilization and costs
￿ incremental cost-effectiveness and cost-utility ratio
￿ health related functioning
￿ health related quality of life
￿ prevalence of falls
Sample size calculation
Sample size calculation was based on an assumed abso-
lute risk reduction from a 20% in the control group to a
7% in the home admission rate of the intervention group.
Power calculation (α = 0.05; β = 0.20) including an esti-
mated drop out rate of 30% resulted in a required sample
size of N = 320 (n = 160 vs. n = 160) using a two-tailed
Chi-square test. The sample size is equally divided among
the two study centers Halle and Leipzig.
Drop-outs
Drop-outs will be documented thoroughly and included
in data analysis to the point of drop-out. Reasons for
drop-out will be reported and analyzed.
Data analysis
Clinical data analysis will be done by the institute for epi-
demiology, biostatistics and medical informatics of the
medical faculty Martin-Luther-University Halle-Witten-
berg.
In a first step adequate descriptive statistics will be used to
compare the intervention group against control group
after randomization. Then all outcomes will be tested in
comparison of the intervention and control group with
multifactorial regression models on an intention-to-treat
basis. Level of significance is determined by 5%. Two-
tailed tests for significance will be used for all statistical
tests.
Precision of results will be specified. Confidence intervals
(95%) will be computed for all primary and secondary
outcomes.
Economic analysis will be conducted by the Health Eco-
nomics Research Unit, University of Leipzig. This involves
calculating costs as well as the cost-effectiveness ratio, i.e.
the ratio of the difference in mean costs and the difference
in mean effects between the intervention and control
group. QALYs based on EQ-5D [12] will be used to meas-
ure health effects in cost-utility analysis. To assess the
uncertainty of the results sensitivity analysis will be per-
formed and cost-effectiveness acceptability curves will be
computed.
Quality assessment
The trial is part of the Nursing Research Network "Mitte-
Süd". A report system is established within the network.
Annual quality reports have to be prepared for the Ger-
man Federal Ministry of Education and Research.
As the conduct of a multi center trial demands high stand-
ards of quality to warrant comparable conditions and
results among the centers all procedures were developed
and documented in joint commissions.
Screening
Screening includes sociodemographic data (age, sex, mar-
ital status and housing conditions), information about
long term care insurance, nursing allowance and degree of
impairment to receive benefits from the long term care
insurance. Furthermore, Activities of Daily Living (ADL)
are checked [13].
Baseline assessment
All participants (intervention and control group) receive
baseline assessment after randomization and the same
assessment at follow-up after 18 months. Cognitive func-
tion is assessed using the Mini Mental State Examination
(MMSE) [14]. The health related quality of life is meas-
ured by the EuroQol-5D [12], including a visual analogue
scale (VAS) to measure patients preferences. Psychosocial
factors are assessed with the Social Situation by NikolausBMC Public Health 2008, 8:185 http://www.biomedcentral.com/1471-2458/8/185
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Study design Figure 1
Study design.
Recruitment:
Generalists‘ practices,
hospitals and registration office
Screening of eligible patients 
Randomization
1st Home visit, N=160
Baseline and intervention assessment
Case conference
Intervention group Control group
2nd Home visit, 2-3 weeks after 1st visit
1st Home visit, N=160 
Baseline assessment
Follow-up, 18 months after 1st visit,
primary outcome: avoidance of nursing
home admission
3rd Home visit, 4 weeks after 2nd visit
Follow-up, 18 months after baseline 
assessment, primary outcome: avoidance of
nursing home admissionBMC Public Health 2008, 8:185 http://www.biomedcentral.com/1471-2458/8/185
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(SoS) [15]and the 5-item version of the Geriatric Depres-
sion Scale (GDS)[16]. This short form was chosen because
it is as effective as the 15-item version of the GDS [17],
which is widely used for depression screening in cogni-
tively unimpaired elderly persons. Moreover, the 5-item
GDS is more an economical version because of reduced
administration time. Details about the functional status
will be determined using the Barthel-Index [18] and the
Instrumental Activities of Daily Living (IADL) [19]. Addi-
tionally, all participants are asked about their history of
falls in the past 12 months. A Questionnaire of Service
Utilization and Costs will be used based on cost diaries
used in earlier studies [20-25].
This questionnaire also includes sociodemographic data
(i.e. age, sex, marital and educational status, life condi-
tions); information about health insurance, long term
care insurance and the degree of impairment to receive
benefits from the long term care insurance. Furthermore
the Chronic Disease Score will be calculated [26].
Intervention assessment
All subjects of the intervention group additionally receive
intervention assessment immediately after baseline
assessment. The current nutrition status is measured by
the Mini Nutrition Assessment (MNA) [27]. Other health
dimensions of elderly persons such as impaired sight or
hearing, urinary or bowel incontinence and loss of func-
tional muscle mass are assessed with the Geriatric Screen-
ing AGAST [28] and the Geriatric Screening by Lachs [29].
These geriatric screenings also determine social activities,
housing conditions, economical conditions and polyp-
harmacy. The Clock-Completion Test [30] will comple-
ment the MMSE for the baseline assessment of cognitive
abilities.
Case conferences
We will conduct interdisciplinary case conferences for all
patients in the intervention group. We intend to collect
several cases for a conference. We will conduct case con-
ferences in the defined period of 3 weeks between first and
second home visit in this way trying to standardize the
procedures. Cases will be prepared and introduced to the
conference group by the visiting investigator. The investi-
gators will invite appropriate health professionals as the
case requires. The professional spectrum of the conference
expert advisory group hereby consists of nurses, a general
practitioner, a nutritionist, a geronto psychiatrist, a physi-
otherapist, a psychologist and a social worker. Recom-
mendations will be worked out for the single patient and
we will document them for the next home visit. The dura-
tion of the preparation, present experts and duration of
the conference will be documented for each patient indi-
vidually.
Home counseling intervention
The last part of the experimental intervention consists of a
counseling intervention. We will address the identified
problems and present the recommendations of our expert
advisory group during this home visit. We estimate the
duration of the second home visit including the coun-
seling with 20–40 minutes.
Booster session
Four weeks after the counseling home visit we will visit
the patients in the intervention group for a third time.
During this visit we want to evaluate which recommenda-
tions the patients already implemented and which not. In
this way we can assess obstacles and facilitators to the rec-
ommendation adherence. Additionally, we have the
opportunity to boost our recommendations from the sec-
ond home visit.
Follow-up
18 months after the first home visit we will assess all par-
ticipants using the same measurement as for the baseline
assessment. Additionally, details about current residence
status, nursing home admission and date of nursing home
admission are included. If a subject cannot be reached by
usual means like telephone or mail, the named contact
person or residents' registration office will be contacted.
All measurements are summarized in Table 1.
Protection of data privacy
We will create a pseudonym for all trial participants to col-
lect and analyze the trial data. Key lists will be stored sep-
arately from the trial data and erased after final data
analysis. Data will be analyzed in a way that no conclu-
sions can be drawn to individual participants. Trial data is
stored in lockable cabinets in lockable rooms. All gained
address data of persons not included in the trial will be
erased after exclusion (prescreening or screening) or non-
inclusion (non-responders of the registration offices' sam-
ples).
Ethical considerations
The study protocol is approved by the ethics committees
of the universities in Halle and Leipzig. If changes to the
study procedures are necessary they will be proposed to
the local ethics committees as amendments. All changes
will be described and discussed in the publication of the
trial's results.
Publication policy
We plan to publish the trial results in a peer reviewed
international Medline-listed journal whether the effective-
ness was shown or not. This mainly serves the purpose to
avoid publication bias. Additionally, we are obliged by
the Federal Ministry of Education and Research to reportBMC Public Health 2008, 8:185 http://www.biomedcentral.com/1471-2458/8/185
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our results within 6 months after study termination. All
trial results will be reported within context to this study
protocol.
Discussion
A significant reduction in nursing home admission rates
over the trial period is expected as a primary outcome. The
study design of a randomized controlled trial is appropri-
ate for the underlying research question. We deem the two
recruitment approaches hospital and general practi-
tioner's practice to be of practical relevance for the Ger-
man health system. Assuming positive results general
practitioners, hospitals or home care agencies seem a
promising way to implement such an intervention in the
German health system.
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